A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

F. Lanza, F. Saraceni, A. Pezzi, M. Martino, A. Bosi, N. Cascavilla, P. Musto, E. Zuffa, M. Tani, C. Cellini, D. Laszlo, F. Bonifazi, on behalf of GITMO (Italian Society for Transplantation)

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)E557-E559
JournalAmerican Journal of Hematology
Issue number9
Publication statusPublished - 2017

Cite this